Abstract
THE formation of the neurotransmitter noradrenaline from 3,4-dihydroxyphenylethylamine (dopamine) is catalysed by the enzyme dopamine-β-hydroxylase (DBH)1. This enzyme is associated both with the catecholamine-containing chromaffin granules in the adrenal medulla2,3 and with the vesicular structures in sympathetic nerve terminals which contain catecholamines4. Furthermore, DBH activity is released with catecholamines into the perfusate after stimulation of either the isolated perfused adrenal gland5 or the isolated perfused spleen6–8. DBH activity has been reported in the serum of both man and the rat9,10. This activity is similar to adrenal and sympathetic nerve DBH activity with regard to cofactor requirements, oxygen requirement and kinetic characteristics9,10. It has been suggested that serum DBH activity might be present as a result of release of enzyme with catecholamines from the adrenal glands and sympathetic nerves. If this is the case, serum DBH activity might be a useful and convenient index of sympathetic-adrenal activity. The work described here was undertaken to investigate both the source of the serum DBH and the effect on this activity of forced immobilization, a procedure which has been used as a model of stress, and which has been shown to release catecholamines from the adrenal gland and increase catecholamine excretion11.
This is a preview of subscription content, access via your institution
Access options
References
Kaufman, S., and Friedman, S., Pharmacol. Rev., 17, 71 (1965).
Kirshner, N., J. Biol. Chem., 226, 821 (1957).
Oka, M., Kajokawa, K., Ohuchi, T., Yoshida, H., and Imaizumi, R., Life Sci., 6, 461 (1967).
Potter, L., and Axelrod, J., J. Pharmacol. Exp. Therap., 142, 299 (1963).
Viveros, O. H., Arqueros, L., and Kirshner, N., Life Sci., 7, 609 (1968).
Geffen, L. B., Livett, B. G., and Rush, R. A., J. Physiol., 204, 58P (1969).
DePotter, W. P., DeSchaepdryver, A. F., Moerman, E. J., and Smith, A. D., J. Physiol., 204, 102P (1969).
Gewirtz, G. P., and Kopin, I. J., Nature, 227, 406 (1970).
Weinshilboum, R., and Axelrod, J., Abst., The Pharmacologist, 12, 214 (1970).
Weinshilboum, R., and Axelrod, J., Circ. Res., 28, 307 (1971).
Kvetnansky, R., and Mikulaj, L., Endocrinology, 87, 738 (1970).
Molinoff, P., Brimijoin, S., Weinshilboum, R., and Axelrod, J., Proc. US Nat. Acad. Sci., 66, 453 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
WEINSHILBOUM, R., KVETNANSKY, R., AXELROD, J. et al. Elevation of Serum Dopamine-β-hydroxylase Activity with Forced Immobilization. Nature New Biology 230, 287–288 (1971). https://doi.org/10.1038/newbio230287a0
Received:
Revised:
Issue date:
DOI: https://doi.org/10.1038/newbio230287a0
This article is cited by
-
Gene Expression of Phenylethanolamine N-Methyltransferase in Corticotropin-Releasing Hormone Knockout Mice During Stress Exposure
Cellular and Molecular Neurobiology (2006)
-
X-ray dose-effect relationship on unscheduled DNA synthesis and spontaneous unscheduled DNA synthesis in mouse brain cells studied in vivo
Radiation and Environmental Biophysics (1989)
-
Plasma dopamine-?-hydroxylase in childhood psychosis
Journal of Autism and Childhood Schizophrenia (1978)
-
Absence of a relationship between sympathetic neuronal activity and turnover of serum dopamine-?-hydroxylase
Naunyn-Schmiedeberg's Archives of Pharmacology (1978)
-
Serum dopamine-?-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol
Psychopharmacology (1976)